Display Settings:

Format

Send to:

Choose Destination
    Mol Cell Biol. 2006 Feb;26(3):735-42.

    Tollip regulates proinflammatory responses to interleukin-1 and lipopolysaccharide.

    Source

    Department of Biochemistry, Ch. des Boveresses 155, CH-1066 Epalinges, Switzerland.

    Abstract

    Activation of interleukin-1 (IL-1) receptor (IL-1R), Toll-like receptor 2 (TLR2), and TLR4 triggers NF-kappaB and mitogen-activated protein kinase (MAPK)-dependent signaling, thereby initiating immune responses. Tollip has been implicated as a negative regulator of NF-kappaB signaling triggered by these receptors in in vitro studies. Here, deficient mice were used to determine the physiological contribution of Tollip to immunity. NF-kappaB, as well as MAPK, signaling appeared normal in Tollip-deficient cells stimulated with IL-1beta or the TLR4 ligand lipopolysaccharide (LPS). Similarly, IL-1beta- and TLR-driven activation of dendritic cells and lymphocytes was indistinguishable from wild-type cells. In contrast, the production of the proinflammatory cytokines, IL-6 and tumor necrosis factor alpha was significantly reduced after IL-1beta and LPS treatment at low doses but not at lethal doses of LPS. Tollip therefore controls the magnitude of inflammatory cytokine production in response to IL-1beta and LPS.

    PMID:
    16428431
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC1347014
    Free PMC Article

    Images from this publication.See all images (5) Free text

    FIG. 1.
    FIG. 3.
    FIG. 5.
    FIG. 2.
    FIG. 4.

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk